ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors Salt Lake City, UT, August 12, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced today the appointment of Leavitt Partners to the ProLung Board of [...]

ProLung Announces the Appointment of Leavitt Partners and Mr. Rich McKeown to its Board of Directors2020-02-17T14:34:38-07:00

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc. ProLung is proud to share that our interim CEO, Jared Bauer, has been highlighted as a "Top Creative Leader Innovating in Business 2019" by Insights Success Magazine. Follow the link to learn more about [...]

ProLung interim CEO, Jared Bauer, is a “Top Creative Leader Innovating in Business 2019” by Insights Success Magazine – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc. Salt Lake City, UT, June 12, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients, announced the appointments of Messers. Jim Hogan, David Nielsen [...]

ProLung Announces Changes to its Board of Directors and Leadership Team to Enhance its Medtech Expertise – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.

ProLung Announces New Office Location as Anchor Tenant at 'The Labs at Northgate' – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / June 10, 2019 / ProLung, Inc. ("ProLung" or the "Company"), which is focused on reducing the time to diagnosis for lung cancer patients, announced today it has started construction on a new [...]

ProLung Announces New Office Location as Anchor Tenant at ‘The Labs at Northgate’ – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc. ProLung is delighted to be honored as the “Med Tech Company of the Year 2019” by Global Health & Pharma. Our ProLung team views external recognition as further validation of our mission to ‘make a difference in time’ [...]

ProLung named Med Tech Company of the Year 2019 by Global Health & Pharma – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc. Salt Lake City, UT, February 1, 2019 – ProLung, Inc. (“ProLung” or the “Company”), which is focused on reducing the time to diagnosis for lung cancer patients with its ProLung Test™, yesterday announced the preliminary results of its PL-208 Validation Study [...]

ProLung Announces Preliminary Results from its PL-208 Clinical Trial and Next-Steps – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc. ProLung, Inc. is honored to be named one of the ‘50 leading companies of the year 2018’ by Silicon Review. Furthermore, our interim CEO, Mr. Jared Bauer, is interviewed in their end of the year special issue where [...]

ProLung named one of 50 Leading Companies of the Year 2018 by Silicon Review – ProLung, Inc.2020-02-17T14:34:38-07:00

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc.

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / December 13, 2018 / ProLung, Inc. (''ProLung'' or the ''Company'') is focused on reducing the time to diagnosis for lung cancer patients. ProLung® conducted its 2018 Annual Meeting of Shareholders (''Meeting'') last week with [...]

ProLung Announces Voting Results from its 2018 Annual Meeting of Shareholders – ProLung, Inc.2020-02-17T14:34:39-07:00

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc.

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc. SALT LAKE CITY, UT / ACCESSWIRE / November 21, 2018 / ProLung, Inc. ("ProLung" or the "Company") is focused on reducing the time to diagnosis for lung cancer patients. Today ProLung announced final results from its PL-209 repeatability study. The ProLung Test is [...]

ProLung Announces Final Results from its PL-209 Repeatability Study – ProLung, Inc.2020-02-17T14:34:39-07:00

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc.

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc. - Consent Solicitation Clearly Failed to Receive the Required Majority - Steven Eror Falsely Claimed Victory for the Third Time SALT LAKE CITY, UT / ACCESSWIRE / October 23, 2018 / ProLung, Inc. ("ProLung" or the "Company") announced today the preliminary results of the consent [...]

ProLung Announces Preliminary Results of Consent Solicitation – ProLung, Inc.2020-02-17T14:34:39-07:00